|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01830 PERFECT MEDICAL
Nominal 
2.620 -0.050 (-1.873%) | 2024/03 - Final HKD(K$) | %Chg (Compare to Final) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | 2020/03 HKD(K$) | |
| Turnover | 1,393,339 | 0.294% | 1,389,261 | 1,349,971 | 1,089,768 | 1,240,950 |
| Cost of Sales | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- |
| 2024/03 - Final HKD(K$) | %Chg (Compare to Final) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | 2020/03 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 383,723 | -1.975% | 391,456 | 378,153 | 358,160 | 450,578 | |
| Taxation | (73,324) | -3.289% | (75,818) | (72,908) | (73,526) | (90,421) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 5,401 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 315,800 | 0.051% | 315,638 | 305,245 | 284,634 | 360,157 | |
| 2024/03 - Final HKD(K$) | %Chg (Compare to Final) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | 2020/03 HKD(K$) | |
| Net Finance Costs / (Income) | (1,342) | -- | 4,608 | 14,349 | 7,732 | 5,617 |
| Depreciation & Amortisation | 201,962 | -9.674% | 223,593 | 219,046 | 171,256 | 154,824 |
| Directors' Emoluments | 40,859 | -4.928% | 42,977 | 36,203 | 28,857 | 25,254 |
| 2024/03 - Final | %Chg (Compare to Final) | 2023/03 | 2022/03 | 2021/03 | 2020/03 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/03 - Final | %Chg (Compare to Final) | 2023/03 | 2022/03 | 2021/03 | 2020/03 | |
| EPS (cts) | 25.100 | -0.791% | 25.300 | 24.800 | 24.300 | 32.200 |
| DPS (cts) | 31.500 | -- | 30.000 | 24.800 | 38.000 | 34.000 |
| Dividend Payout Ratio (%) | 125.498% | -- | 118.577% | 100.000% | 156.379% | 105.590% |
| Cash flow per share ($) | 0.396 | -- | 0.449 | 0.418 | 0.511 | 0.577 |
| NBV per share ($) | 0.396 | -- | 0.487 | 0.399 | 0.560 | 0.609 |
| Remarks: | Real time quote last updated: 22/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 315,800 |
| %Change | 0.051% |
| EPS / (LPS) | HKD 0.251 |
| NBV Per Share ($) | HKD 0.396 |